Regeneron to invest over $3 billion to boost US manufacturing
(Reuters) -Regeneron Pharmaceuticals said on Tuesday it has signed a deal worth more than $3 billion with contract drug developer Fujifilm Diosynth, potentially doubling its U.S. manufacturin...
Novo shares down on Eli Lilly’s positive obesity pill data
Investing.com -- Novo Nordisk (NYSE: NVO ) shares sank more than 7% in Copenhagen after Eli Lilly (NYSE: LLY ) released promising trial results for its experimen...
L’Oreal shares rise on strong Chinese sales, despite U.S. slowdown
Investing.com -- Shares of cosmetics giant L’Oreal saw an increase of up to 2.3% as the company’s like-for-like sales growth surpassed expectations. This boost was mainly attributed ...
